AIM (AIM ImmunoTech) Net earnings per share (EPS TTM)
AIM ImmunoTech's critical dependence on a single drug creates binary risks, as confirmed by the YoY EPS change on a rolling 12-month basis on GURU.Markets, where 84.30 reflects the metric's baseline. Brand stability is supported by the trust of patients with chronic fatigue syndrome, while strategic alliances with oncology centers develop Ampligen, enhancing M&A potential within the sector.
AIM ImmunoTech Inc. - analytical breakdowns and key metrics (AIM)
- market value and analyst target forecast:
- business market valuation indicators:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital AIM ImmunoTech|AIM - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient AIM ImmunoTech, Inc.|AIM - Company Debts|Debt to Book Value AIM ImmunoTech, Inc.|AIM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings AIM ImmunoTech|Interim Coverage Ratio aimimmuno.com
- earnings and valuation multiples information:
AIM - Company Net Income|Future Profit AIM ImmunoTech|AIM - Price to Earnings Ratio|Projected Price to Earnings aimimmuno.com|AIM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AIM ImmunoTech, Inc.|AIM - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months AIM ImmunoTech|AIM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months aimimmuno.com|AIM - Net earnings per share growth this year|Projected earnings per share increase next year AIM ImmunoTech
Initial company analysis:AIM ImmunoTech
This indicator measures the annual growth rate of net income per share over a twelve-month period. An increase in this metric signals the business's ability to generate added value amid tight monetary policy. By analyzing the annual TTM net income per share dynamics, an investor determines the degree of the asset's undervaluation. For AIM ImmunoTech (AIM), this metric is critical due to the polarization of opinions regarding the company, as it allows for a comparison of financial results with the professional confidence physicians place in the potential of Ampligen.
Direct competitors
argenx.com (ARGX) - Net earnings per share for the last 12 months|BNTX (BioNTech) - Net earnings per share for the last 12 months|Abivax Corp (ABVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ADMA Bio|Earnings per share for the last 12 months PTGX (Protagonist Corp)|Net earnings per share (EPS TTM) IMVT|KNSA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) GRFS (Grifols)|Net earnings per share (EPS TTM) Adaptive Biotech ADPT|Celldex - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Aurinia Corp AUPH|BioCryst (BCRX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months veratx.com|Net earnings per share for the last 12 months DNTH|PHVS: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABCL|Net earnings per share for the last four quarters Tourmaline|Earnings per share for the last twelve months Precigen, Inc. PGEN|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|Upstream Bio, Inc. (UPB) - Net earnings per share for the last 12 months|ZBIO (Zenas Biopharma, Inc.) - Net earnings per share for the last 12 months|Immunome Bio (IMNM) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Gossamer Bio, Inc.|Earnings per share for the last 12 months KALV (kalvista.com)|Earnings per share for the last twelve months Septerna (SEPN)|PVLA - Net earnings per one share for the last twelve months|Savara Corp - Net earnings per share for the last 12 months|Earnings per share for the last four quarters RIGL (Rigel Corp)|AnaptysBio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months astriatx.com|ENGN: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months rapt.com|JBIO (Aerovate Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ACRS: Earnings per share for the trailing year|Net earnings per share (EPS TTM) KYTX|Net earnings per share (EPS TTM) tizianalifesciences.com (TLSA)|Net earnings per share (EPS TTM) CABA (Cabaletta Bio)|Net earnings per share for the last four quarters Ventyx Biosciences Inc. (VTYX)|THTX - Earnings per share for the last twelve months|Avalo Therapeutics Inc (AVTX) - Net earnings per share for the last 12 months|Eledon Pharmaceuticals (ELDN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AGEN (agenusbio.com)|CLYM (Climb Bio) - Net earnings per share (EPS TTM)|ZURA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATYR|Net earnings per share (EPS TTM) adagene.com (ADAG)|Earnings per share for the last twelve months Ikena Oncology IMA|Earnings per share for the trailing year STTK|EQ - Earnings per share for the last twelve months|Connect Biopharma (CNTB) - Net earnings per share for the last 12 months|IMUX: Net earnings per share (EPS TTM)|Atara Bio (ATRA) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IFRX|XFOR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ACET|Net earnings per share for the last four quarters celularity.com|Earnings per share for the last twelve months INmune Bio Corp INMB|BRNS - Net earnings per share for the last 12 months|KZR - Earnings per share for the last twelve months|sabbiotherapeutics.com (SABS) - Net earnings per share for the last 12 months|AKTX (Akari Therapeutics Plc) - Net earnings per share for the last 12 months|Enlivex Therapeutics Ltd. (ENLV) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Q32 Bio Inc|Earnings per share for the last 12 months GOVX (GeoVax Corp)|Net earnings per share (EPS TTM) EDSA|IBIO - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CARM (Carisma Therapeutics Inc.)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd XTLB|Bolt Bio - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters HCW Biologics Inc. HCWB|aptevotherapeutics.com (APVO) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Aditxt, Inc.|Net earnings per share for the last 12 months GRI|XRTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HIND|Net earnings per share for the last four quarters Revelation Biosciences Corp|Earnings per share for the last twelve months Indaptus Therapeutics INDP|SCNI - Net earnings per share for the last 12 months|CALI - Earnings per share for the last twelve months|Affimed (AFMD) - Net earnings per share for the last 12 months|ALLK (allakos.com) - Net earnings per share for the last 12 months|HOOKIPA Pharma (HOOK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IGM Biosciences Inc.|Earnings per share for the last 12 months ITOS (iteostherapeutics.com)|Earnings per share for the last twelve months Ocean Biomedical (OCEA)|TCBP - Net earnings per one share for the last twelve months|Third Harmonic Bio, Inc - Net earnings per share for the last 12 months
